The impact of early de novo donor-specific antibodies on lung transplant outcomes: Is timing everything?

被引：1
|
作者：
King, Christopher S. [1 ]
Cochrane, Adam B. [2 ]
机构：
[1] Inova Fairfax Hosp, Adv Lung Dis & Lung Transplant Clin, 618 S Royal St, Falls Church, VA 22314 USA
[2] Inova Fairfax Hosp, Adv Lung Dis Clin, Dept Pharm, Falls Church, VA USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2016年 / 35卷 / 09期
关键词：
BRONCHIOLITIS OBLITERANS SYNDROME; MEDIATED REJECTION; INTERNATIONAL SOCIETY; HLA-ANTIBODIES; HEART;
D O I：
10.1016/j.healun.2016.07.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1057 / 1058
页数：2
相关论文
共 50 条
  • [1] Early clearance vs persistence of de novo donor-specific antibodies following lung transplantation
    Islam, Ana K.
    Sinha, Neeraj
    DeVos, Jennifer M.
    Kaleekal, Thomas S.
    Jyothula, Soma S.
    Teeter, Larry D.
    Nguyen, Duc T. M.
    Eagar, Todd N.
    Moore, Linda W.
    Puppala, Mamta
    Wong, Stephen T. C.
    Knight, Richard J.
    Frost, Adaani E.
    Graviss, Edward A.
    Gaber, A. Osama
    CLINICAL TRANSPLANTATION, 2017, 31 (08)
  • [2] De novo DQ donor-specific antibodies are associated with worse outcomes compared to non-DQ de novo donor-specific antibodies following heart transplantation
    Cole, Robert Townsend
    Gandhi, Jonathan
    Bray, Robert A.
    Gebel, Howard M.
    Morris, Alanna
    McCue, Andrew
    Yin, Michael
    Laskar, S. Raja
    Book, Wendy
    Jokhadar, Maan
    Smith, Andrew
    Duc Nguyen
    Vega, J. David
    Gupta, Divya
    CLINICAL TRANSPLANTATION, 2017, 31 (04)
  • [3] Carfilzomib versus rituximab for treatment of de novo donor-specific antibodies in lung transplant recipients
    Razia, Deepika
    Hu, Chengcheng
    Cherrier, Lauren
    Nasar, Aasya
    Walia, Rajat
    Tokman, Sofya
    TRANSPLANT IMMUNOLOGY, 2022, 75
  • [4] Persistence of de novo donor-specific HLA-antibodies after lung transplantation: A potential marker of decreased patient survival
    Schmitzer, M.
    Winter, H.
    Kneidinger, N.
    Meimarakis, G.
    Dick, A.
    Schramm, R.
    Klotz, L. V.
    Preissler, G.
    Strobl, N.
    von Dossow, V.
    Schneider, C.
    Weig, T.
    Hatz, R.
    Kauke, T.
    HLA, 2018, 92 (01) : 24 - 32
  • [5] The detrimental impact of persistent vs an isolated occurrence of de novo donor-specific antibodies on intermediate-term renal transplant outcomes
    Loucks-DeVos, Jennifer M.
    Eagar, Todd N.
    Gaber, A. Osama
    Patel, Samir J.
    Teeter, Larry D.
    Graviss, Edward A.
    Knight, Richard J.
    CLINICAL TRANSPLANTATION, 2017, 31 (08)
  • [6] Early donor-specific antibodies in lung transplantation: Risk factors and impact on survival
    Ius, Fabio
    Sommer, Wiebke
    Tudorache, Igor
    Kuehn, Christian
    Avsar, Murat
    Siemeni, Thierry
    Salman, Jawad
    Hallensleben, Michael
    Kieneke, Daniela
    Greer, Mark
    Gottlieb, Jens
    Haverich, Axel
    Warnecke, Gregor
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (12) : 1255 - 1263
  • [7] De Novo Donor-Specific HLA Antibodies: Biomarkers of Pancreas Transplant Failure
    Mittal, S.
    Page, S. L.
    Friend, P. J.
    Sharples, E. J.
    Fuggle, S. V.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (07) : 1664 - 1671
  • [8] Comparison of de novo donor-specific antibodies between living and cadaveric lung transplantation
    Gochi, Fumiaki
    Chen-Yoshikawa, Toyofumi Fengshi
    Kayawake, Hidenao
    Ohsumi, Akihiro
    Tanaka, Satona
    Yamada, Yoshito
    Yutaka, Yojiro
    Nakajima, Daisuke
    Hamaji, Masatsugu
    Yurugi, Kimiko
    Hishida, Rie
    Date, Hiroshi
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (07) : 607 - 613
  • [9] Renal transplant outcomes and de novo donor-specific anti-human leukocyte antigen antibodies: a systematic review
    Sharma, Ankit
    Lewis, Joshua R.
    Lim, Wai H.
    Palmer, Suetonia
    Strippoli, Giovanni
    Chapman, Jeremy R.
    Alexander, Stephen I.
    Craig, Jonathan C.
    Wong, Germaine
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 (08) : 1472 - 1480
  • [10] Microcirculation Inflammation Associates With Outcome in Renal Transplant Patients With De Novo Donor-Specific Antibodies
    de Kort, H.
    Willicombe, M.
    Brookes, P.
    Dominy, K. M.
    Santos-Nunez, E.
    Galliford, J. W.
    Chan, K.
    Taube, D.
    McLean, A. G.
    Cook, H. T.
    Roufosse, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (02) : 485 - 492
12345